Solid Biosciences (SLDB) announced a collaboration with Mayo Clinic seeking to advance a cutting-edge AAV gene therapy platform for the development of next-generation therapies to treat sudden cardiac ...
Rochester, Minn.-based Mayo Clinic has begun integrating action items from genetic tests into health records for more than 100,000 patients who participated in an exome study for biomedical ...